Two Sigma Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.7M Buy
782,540
+510,700
+188% +$20.8M 0.02% 766
2025
Q4
$11M Buy
271,840
+107,403
+65% +$4.67M 0.02% 1062
2025
Q3
$7.73M Buy
164,437
+98,729
+150% +$5.12M 0.01% 1113
2025
Q2
$3.42M Sell
65,708
-33,970
-34% -$1.86M 0.01% 1483
2025
Q1
$6.02M Buy
+99,678
New +$6.42M 0.01% 1020
2024
Q4
Sell
-10,773
Closed -$775K 3244
2024
Q3
$775K Sell
10,773
-28,012
-72% -$1.98M ﹤0.01% 2258
2024
Q2
$2.69M Sell
38,785
-25,184
-39% -$1.84M 0.01% 1357
2024
Q1
$5.12M Sell
63,969
-67,381
-51% -$6.01M 0.01% 957
2023
Q4
$14.4M Sell
131,350
-86,459
-40% -$8.94M 0.03% 533
2023
Q3
$22M Buy
217,809
+207,294
+1,971% +$23.8M 0.06% 359
2023
Q2
$1.43M Buy
10,515
+115
+1% +$14K ﹤0.01% 1724
2023
Q1
$1.08M Sell
10,400
-49,874
-83% -$4.82M ﹤0.01% 1826
2022
Q4
$5.34M Buy
60,274
+14,390
+31% +$1.19M 0.02% 823
2022
Q3
$3.68M Sell
45,884
-46,358
-50% -$4.37M 0.01% 872
2022
Q2
$8.83M Buy
+92,242
New +$11.1M 0.03% 557
2021
Q4
Sell
-27,607
Closed -$3.61M 4359
2021
Q3
$3.61M Sell
27,607
-10,562
-28% -$1.38M 0.01% 1481
2021
Q2
$5.25M Buy
38,169
+18,451
+94% +$2.53M 0.01% 1169
2021
Q1
$2.58M Buy
+19,718
New +$2.37M 0.01% 1512
2020
Q4
Sell
-26,300
Closed -$2.07M 3388
2020
Q3
$2.07M Sell
26,300
-67,459
-72% -$5.5M 0.01% 1279
2020
Q2
$6.75M Buy
93,759
+7,715
+9% +$537K 0.03% 525
2020
Q1
$4.93M Buy
86,044
+55,313
+180% +$5.1M 0.04% 513
2019
Q4
$3.44M Buy
30,731
+21,550
+235% +$2.3M 0.01% 1194
2019
Q3
$883K Buy
+9,181
New +$862K ﹤0.01% 2090
2019
Q1
Sell
-22,906
Closed -$1.47M 3082
2018
Q4
$1.47M Buy
+22,906
New +$1.57M 0.01% 1414
2018
Q2
Sell
-78,533
Closed -$4.97M 3357
2018
Q1
$4.97M Buy
+78,533
New +$4.69M 0.02% 953
2016
Q2
Sell
-46,255
Closed -$1.94M 2936
2016
Q1
$1.94M Sell
46,255
-43,811
-49% -$1.72M 0.01% 1198
2015
Q4
$3.97M Buy
90,066
+54,381
+152% +$2.36M 0.02% 758
2015
Q3
$1.7M Sell
35,685
-7,345
-17% -$403K 0.01% 915
2015
Q2
$2.51M Sell
43,030
-45,317
-51% -$2.44M 0.01% 1066
2015
Q1
$4.46M Buy
88,347
+19,730
+29% +$967K 0.02% 772
2014
Q4
$3.08M Sell
68,617
-59,185
-46% -$2.48M 0.02% 828
2014
Q3
$4.71M Sell
127,802
-17,967
-12% -$713K 0.02% 635
2014
Q2
$6.44M Buy
145,769
+24,862
+21% +$1.13M 0.03% 629
2014
Q1
$5.25M Buy
120,907
+73,339
+154% +$3.27M 0.03% 613
2013
Q4
$2.02M Buy
47,568
+3,801
+9% +$144K 0.01% 990
2013
Q3
$1.49M Sell
43,767
-44,275
-50% -$1.44M 0.01% 876
2013
Q2
$2.75M Buy
+88,042
New +$2.86M 0.02% 749

Other funds holding CNMD

Two Sigma Investments's CNMD Position: Q1 2026 in Review

Two Sigma Investments increased its CONMED (CNMD) stake by 188% in Q1 2026, buying an estimated $20.8M and bringing the position to 782,540 shares worth $27.7M. The position accounts for 0.02% of the portfolio, ranked #766.

Two Sigma Investments first reported a position in CNMD in Q2 2013 and has held it in 37 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Two Sigma Investments held 782,540 shares of CONMED worth $27.7M as of Q1 2026.
  • Two Sigma Investments bought 510,700 CONMED shares in Q1 2026, an estimated $20.8M.
  • CONMED made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #766 holding.
  • Two Sigma Investments first reported a position in CONMED in Q2 2013 and has held it in 37 quarters since.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.